1Y Close · As of Aug 26, 2026
SeouLinBioscience operates in the Wholesale Trade sector.
Legal name: SeouLinBioscienceCO.,LTD.
In fiscal year 2025, SeouLinBioscience (038070) reported revenue of 77.1 billion KRW, up 2.2% from 75.4 billion KRW a year earlier.
Operating profit was 692 million KRW and net income was 574 million KRW in the same year.
As of the Aug 26, 2026 close, the market capitalization was 41.3 billion KRW, with a P/B of 0.48.
These figures can be verified in the DART filing (receipt no. 20260318000909).
Checks
1 of 8 checked items currently applicable.
Market Cap & Price: Market cap is above the delisting threshold.
Administrative Designation: No administrative designation criteria met.
Audit Opinion: Audit opinion: Unqualified (clean).
Capital Increase: No capital-increase filings in the last 180 days.
Treasury Stock: No treasury stock filings.
Embezzlement & Litigation: No embezzlement or litigation filings in the last 180 days.
Major Shareholder Change: No major shareholder changes in the last 180 days.
Market Action: No market actions recorded in the last 180 days.
Recent Filings
| Date | Filing |
|---|---|
| 2026-08-13 | Conversion Price Adjustment |
| 2026-08-13 | Semi-Annual Report (2026.06) |